Keyphrases
Disease Severity
100%
Interleukin-22 (IL-22)
100%
Th17 Cytokines
100%
Disease Outcome
100%
Cytokine Activation
100%
Peripartum Cardiomyopathy
100%
Tumor Necrosis Factor-α
66%
Interleukin-17 (IL-17)
50%
Interleukin-2
50%
Interleukin-4 (IL-4)
50%
Event-free Survival
50%
Inflammatory Cytokines
33%
Inotropic Support
33%
Immune Regulation
33%
Mechanical Support
33%
NYHA Class
33%
Interferon-α (IFN-α)
16%
Clinical Outcomes
16%
Adverse Events
16%
Cytokine Levels
16%
T Helper 17 (Th17)
16%
Serum Levels
16%
Echocardiography
16%
Severe Disease
16%
Survival Outcomes
16%
Immune Dysregulation
16%
Factor Level
16%
Soluble interleukin-2 Receptor (sIL-2R)
16%
Regulatory Response
16%
Myocardial Recovery
16%
IL-2 Receptor
16%
Interleukin (IL)-2
16%
Development Outcomes
16%
Regulatory Cytokines
16%
Immunology and Microbiology
Cytokine
100%
Interleukin 22
85%
Tumor Necrosis Factor
57%
Interleukin 4
42%
Event Free Survival
42%
Interleukin 17
42%
Interleukin 2
28%
Proinflammatory Cytokine
28%
Inotropism
28%
Interleukin 2 Receptor
28%
interferon
14%
Blood Level
14%
ELISA
14%
Immune Dysregulation
14%
IL-2 Receptor
14%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Interleukin 22
85%
Tumor Necrosis Factor
57%
Interleukin 2
57%
Interleukin 4
42%
Event Free Survival
42%
Interleukin 17
42%
Proinflammatory Cytokine
28%
Inotropism
28%
Blood Level
14%
IL-2 Receptor
14%
Interferon
14%